Seongcheol Kim

Title: Seongcheol Kim: Innovator in RNA Technology

Introduction

Seongcheol Kim is a prominent inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of RNA technology, particularly through his innovative patent related to self-circularization RNA constructs. His work has the potential to advance various applications in biotechnology and medicine.

Latest Patents

Seongcheol Kim holds a patent for a self-circularization RNA construct. This construct can be expressed in a DNA vector and simultaneously circularized through a self-targeting and splicing reaction to form a circular RNA (circRNA). The circRNA can consist solely of a gene of interest, which may be coding, non-coding, or a combination of both. This innovation allows for the rapid expression of peptides or proteins. The circular structure of the formed circRNA provides stability and a high half-life, as the 5′ and 3′ ends are not exposed. This technology enables the production of functional RNA, including miRNA, anti-miRNA, siRNA, shRNA, aptamers, and mRNA vaccines, among others.

Career Highlights

Seongcheol Kim is currently associated with Rznomics Inc., where he continues to push the boundaries of RNA research. His work is instrumental in developing stable circRNA that can be utilized in various therapeutic applications.

Collaborations

Seongcheol Kim collaborates with notable colleagues, including Seong-Wook Lee and Kyung Hyun Lee. Their combined expertise contributes to the advancement of RNA technology and its applications.

Conclusion

Seongcheol Kim's innovative work in self-circularization RNA constructs represents a significant advancement in biotechnology. His contributions have the potential to impact various fields, including gene therapy and vaccine development.